Skip to main content
Premium Trial:

Request an Annual Quote

Just One Word: Bio-PTA

Among the biomaterials production firm he profiles this week, Plastics News' Mike Verespej discusses how the Lansing, Mich.-based Draths Corp. is using synthetic biology approaches to produce muconic acid as a building block for renewable bio-purified terephthalic acid, or bio-PTA. Director of Business Development Allen Julian tells Plastic News that Draths aims "to be a monomer producer, build and operate the first plant and then add plants or license the technology to others" for future biopolymer production efforts. "Our two core components are the fermentation technology and our synthetic biology knowledge," Allen says, adding that the company's "goal is to have a 1,000-kilogram pilot plant by 2012, a 10-million-kg demonstration plant between 2013 and 2014, and a 100 million-kg commercial plant by 2015." Further, he tells Plastics News that with its synthetic biology coupled to fermentation-based approach, "we expect our bio-PTA costs to be fully competitive with petrochemical alternatives."

The Scan

Rise of BA.5

The New York Times reports that the Omicron subvariant BA.5 has become the dominant version of SARS-CoV-2 in the US.

UK Health Secretary Resigns

Sajid Javid, the UK health secretary, resigned along with Chancellor Rishi Sunak, saying they cannot work with Prime Minister Boris Johnson's government, CNN reports.

Clones From Freeze-Dried Cells

A team in Japan has cloned mice from freeze-dried skin cells, according to the Guardian.

Genome Research Papers on Craniosynostosis, Macaque Retrotransposition, More

In Genome Research this week: structural variants in craniosynostosis, LINE-1 activity in rhesus macaque brain, and more.